Hydrochloric Acid

Hydrochloric Acid

SCHEMBL29501016

CCN(CC)Cc1ccccc1OC(=O)N(C)C.Cl

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BCHE known ✓ P06276 4/20 0.47
ACHE known ✓ P22303 4/20 0.47
TSHR P16473 3/20 0.66
ALDH1A1 P00352 1/20 0.49
NCEH1 Q6PIU2 3/20 0.46
APP P05067 2/20 0.44
PKM P14618 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10617746 0.89 ACHE (0.61) TSHRBCHEACHEAPP
Bromomethane SCHEMBL10614766 0.86 ACHE (0.59) TSHRBCHEACHEAPP
Bromomethane SCHEMBL10617778 0.86 ACHE (0.59) TSHRBCHEACHEAPP
Bromomethane SCHEMBL10614793 0.86 ACHE (0.59) TSHRBCHEACHEAPP
Bromomethane SCHEMBL10614806 0.86 ACHE (0.59) TSHRBCHEACHEAPP
Bromomethane SCHEMBL10617745 0.86 ACHE (0.59) TSHRBCHEACHEAPP
SCHEMBL10614802 0.86 TSHR (0.72) TSHRALDH1A1BCHENCEH1PKM
SCHEMBL10778554 0.84 TSHR (0.68) TSHRALDH1A1NCEH1PKMNPC1
SCHEMBL10614878 0.81 ACHE (0.56) BCHEACHEAPP
SCHEMBL10615666 0.81 TSHR (0.68) TSHRALDH1A1BCHEACHENCEH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4728537-A1 SYNTHESIS AND INTEGRATION OF NOBLE GAS RADIOISOTOPE POWER SYSTEMS The Charles Stark Draper Laboratory, Inc. (US) 2026-04-22 EP claimed
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 EP claimed
US-12522624-B2 Electroluminescent material and device thereof Beijing Summer Sprout Technology Co., Ltd. (CN) 2026-01-13 US claimed
US-12394534-B2 Nuclear voltaic power-source NDB INC. (US) 2025-08-19 US claimed
WO-2024259049-A1 SYNTHESIS AND INTEGRATION OF NOBLE GAS RADIOISOTOPE POWER SYSTEMS THE CHARLES STARK DRAPER LABORATORY, INC. (US) 2024-12-19 WO claimed
WO-2024121084-A1 PREPARATION OF NITRILES MERCK PATENT GMBH (DE) 2024-06-13 WO claimed
CN-114974630-B Molten salt reactor power measurement method and system 中国科学院上海应用物理研究所 2024-05-10 CN claimed
US-20230301189-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-21 US claimed
US-20230187094-A1 NUCLEAR VOLTAIC POWER-SOURCE NDB INC. (US) 2023-06-15 US claimed
US-20220274998-A1 ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-09-01 US claimed
CN-114974630-A Method and system for measuring power of molten salt reactor 中国科学院上海应用物理研究所 2022-08-30 CN claimed
US-20220231232-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-07-21 US claimed
US-20220177502-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-06-09 US claimed
US-20260146024-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Apparatus, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-05-28 US disclosed
EP-4728537-A1 SYNTHESIS AND INTEGRATION OF NOBLE GAS RADIOISOTOPE POWER SYSTEMS The Charles Stark Draper Laboratory, Inc. (US) 2026-04-22 EP disclosed
EP-4078692-B1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2026-03-18 EP disclosed
US-11407766-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2022-08-09 US disclosed
US-20220120920-A1 INDIRECT CONVERSION NUCLEAR BATTERY USING TRANSPARENT SCINTILLATOR MATERIAL U.S. DEPARTMENT OF ENERGY 2022-04-21 US disclosed
CN-109942635-B Phenyl tricarbazole spiro derivative, preparation method and application thereof, and electronic device 苏州大学 2022-04-12 CN disclosed
US-11300578-B2 Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system ROCHE MOLECULAR SYSTEMS, INC. (US) 2022-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274998-A1 ELECTROLUMINESCENT DEVICE H1-2, H1-0, L1CAM BCHE 2725/4885ACHE 423/4885TSHR 2502/4885
US-20220177502-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF IDO1, AZI2, YTHDF2 BCHE 1626/4885ACHE 321/4885TSHR 3702/4885
US-20260146024-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Apparatus, and Lighting Device NR2E3, CCNE2, CCND3 BCHE 3312/4885ACHE 2858/4885TSHR 1301/4885
US-11407766-B2 Materials for organic electroluminescent devices OR10J3, EPCAM, L1CAM BCHE 694/4885ACHE 223/4885TSHR 4759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.